Company news
Universe Pharmaceuticals Inc (NASDAQ:UPC) news
Universe Pharmaceuticals Inc news releases on 6ix. Latest, Jun 26, 2026: Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical…
Press releases & updates
Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio
June 26, 2026
Universe Pharmaceuticals INC Announces Effective Date of Dual-Class Share Structure
February 11, 2026
Universe Pharmaceuticals INC Announces Share Consolidation
March 20, 2025
Universe Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual Report
February 25, 2025
Universe Pharmaceuticals : Announces $15 Million Registered Direct Offering Form 6 K
December 12, 2024
Universe Pharmaceuticals INC Announces $15 Million Registered Direct Offering
December 8, 2024
UNIE PHARPAR : Universe Pharmaceuticals INC Announces Share Consolidation Form 6 K
November 13, 2024
Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
November 1, 2024
Universe Pharmaceuticals : Results of the Universe Pharmaceuticals INC 2024 Annual General Meeting Form 6 K
September 27, 2024
Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2024
September 19, 2024
Universe Pharmaceuticals : Closing of Public Offering Form 6 K
July 18, 2024
Universe Pharmaceuticals INC Reports Fiscal Year 2023 Financial Results
January 29, 2024
Universe Pharmaceuticals : Receipt of Nasdaq Notification Regarding Compliance with Nasdaq Minimum Bid Price Requirement - Form 6-K
August 16, 2023
Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares
August 3, 2023
Universe Pharmaceuticals : Results of the Universe Pharmaceuticals INC 2023 Annual General Meeting - Form 6-K
July 5, 2023
Universe Pharmaceuticals INC Announces Inclusion of Six Products into the First Edition of Catalogue of Medicine for Patients Infected with COVID-19
December 20, 2022
Universe Pharmaceuticals INC Regains Compliance with Nasdaq Minimum Bid Price Requirement
November 13, 2022
Universe Pharmaceuticals : Results of the Universe Pharmaceuticals INC 2022 Annual General Meeting - Form 6-K
September 28, 2022
Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2022
August 15, 2022
Universe Pharmaceuticals INC Announces Strategic Partnership with Lian-Ou Health to Develop its Digital Marketing and Sales on E-Commerce Platforms
March 29, 2022
Universe Pharmaceuticals INC Reports Fiscal Year 2021 Financial Results
January 30, 2022
Universe Pharmaceuticals INC Announces Strategic Alliance with Jiangxi Province Institute of Materia Medica to Conduct Research on Traditional Chinese Medicine
January 3, 2022
Universe Pharmaceuticals INC Announces Strategic Alliance with Jinggangshan University for Study on the Chemical Constituents of Certain Traditional Chinese Medicine
December 28, 2021
Universe Pharmaceuticals INC Appoints Mr. Baochang Liu as Chief Operating Officer
December 14, 2021
Universe Pharmaceuticals INC Announces Strategic Alliance with Kitanihon Pharmaceutical Co., Ltd. to Address the Market Demand for Kampo Medicine and High-end Traditional Chinese Medicine
December 12, 2021
Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2021
August 1, 2021
Universe Pharmaceuticals INC to Announce Unaudited Financial Results for The First Six Months of Fiscal Year 2021 on August 2, 2021
July 29, 2021
Universe Pharmaceuticals INC Enters into Letter of Intent for Strategic Cooperation with Kitanihon Pharmaceutical Co., Ltd.
May 24, 2021
Universe Pharmaceuticals INC Announces Full Exercise of Underwriter’s Over-Allotment Option in the Public Offering
March 30, 2021
Universe Pharmaceuticals INC Announces Closing of Initial Public Offering
March 24, 2021
Universe Pharmaceuticals INC Announces Pricing and Trading of Initial Public Offering
March 22, 2021